Plus500 does not provide CFD services to residents of the United States. Visit our U.S. website at us.plus500.com.

Denali Therapeutics DNLI

14.65 -0.78%
High: 14.89 Low: 14.51

Denali Therapeutics Inc. San Francisco-based biotechnology company, focusing on medicines for neurodegenerative diseases. Yahoo! Finance

Traders' Sentiments

Info

Denali Therapeutics Inc. San Francisco-based biotechnology company, focusing on medicines for neurodegenerative diseases. Yahoo! Finance

Spread 0.11 Spread (%) 0.75%
Overnight funding - Buy -0.05813% Overnight funding - Sell -0.02965%
Initial margin 20.00% Maintenance margin 10.00%
Leverage 1:5 Expires daily No

Related Instruments

Information to start with Denali Therapeutics

  1. Info on what shifts the Denali Therapeutics price
  2. Steps to open and verify a Plus500 account
  3. Plan a Denali Therapeutics trading strategy

Related News & Market Insights

Why Plus500?

Protected & secure

Your data is safe and your funds are kept in segregated bank accounts, in accordance with regulatory requirements.

Professional support

Get around-the-clock dedicated customer service in multiple languages.

Regulated

Plus500CY Ltd is authorised and regulated by the Cyprus Securities and Exchange Commission (Licence No. 250/14).

Reliable

Plus500 Ltd is a FTSE 250 company listed on the London Stock Exchange’s Main Market for Listed Companies.

Denali Therapeutics FAQ

The current price of Denali Therapeutics is 14.65*.

Today's price range is between 14.51 and 14.89*.

Denali Therapeutics has changed by -0.78% today.

Denali Therapeutics has 0% Buyers and 0% Sellers.

Need Help?

24/7 Support